ArticleJournal of gynecologic oncology2024

Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey.

Ji Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.